CurrentCignaPolicy 0372
Adjunctive oral cancer screening systems
This Cigna Coverage Policy governs the coverage position for adjunctive oral cancer screening systems (light-based visualization devices, chemiluminescence devices, lesion marking systems, and related adjunctive tests) as adjuncts to conventional visual and tactile oral examinations, and references laboratory saliva testing guidance separately.
Policy Summary
PayerCigna
PolicyAdjunctive oral cancer screening systems
Policy CodePolicy 0372
Change TypeAdministrative update; prior removals
Effective Date
Next Review Date
Key ActionClaims for adjunctive oral cancer screening systems (listed devices and similar adjunctive tests) will be denied as experimental, investigational or unproven when billed for screening or detection of oral cancer as an adjunct to conventional examination.
POLICY UPDATE CHANGES
Annual Review dated 01/15/2025: No clinical policy statement changes; hyperlink added for Laboratory Management Clinical Guidelines.
Focused Review dated 11/01/2024: No clinical policy statement changes.
Annual Review dated 12/03/2023: Removed statements on Saliva Testing and oral CDX Brush Biopsy.
1Policy position: adjunctive systems not covered
>10Named devices listed as not covered
1Standard of care required: biopsy/histology
2